Schedule 13G ownership disclosure

Ventyx Biosciences Inc

Common Stock · CUSIP: 92332V107

Event date: 2026-01-31

Filing-level shares
237,358
Percent of class
0.3%
  • Morgan Stanley

    Shares: 237,358 · Class: 0.3%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000895421-26-000009
Form type
SCHEDULE 13G/A
Filer
MORGAN STANLEY
CIK
CIK 895421
Filed
Feb 06, 2026
Reporting period
Jan 31, 2026
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub